Global Fund

World Vision and the Global Fund

Global Fund logo

The Global Fund is a partnership designed to accelerate the end of HIV/AIDS, tuberculosis (TB) and malaria as epidemics. Since its creation in 2002, the Global Fund has disbursed more than US$60.4 billion to respond to HIV, TB, malaria and COVID-19 and for programmes to strengthen health systems across more than 120 countries as of June 2023, making it one of the largest funders of global health.

Programmes supported by the Global Fund have saved 70 million lives and provided prevention, treatment and care services to hundreds of millions of people, helping to revitalise entire communities, strengthen local health systems, and improve economies. 

 

World Vision and the Global Fund Portfolio

 

World Vision has been a trusted partner of the Global Fund since its inception in 2002, working alongside national governments, CCMs, civil society, and communities to deliver high-impact, evidence-based programmes in some of the world’s most fragile and underserved settings.

From 2002 to 2024, World Vision has implemented 188 Global Fund grants as both Principal Recipient (PR) and Sub-recipient (SR) across 44 countries, with a cumulative portfolio value exceeding US$1.4 billion, including significant match funding. This portfolio spans HIV, TB, malaria, and multi-disease grants, implemented across sub-Saharan Africa, Asia-Pacific, Latin America, and other high-burden regions.

Across recent grant cycles, World Vision has maintained a strong and diverse portfolio, combining disease-specific programming with investments in community systems, health workforce strengthening, supply chains, data systems, and governance. Our work includes malaria programmes in countries such as Angola, Malawi, Mozambique, the Central African Republic, and Solomon Islands; TB programmes in Somalia, India, Myanmar, Haiti, and Sierra Leone; and HIV and TB/HIV programmes in Eswatini, Papua New Guinea, Thailand, Nicaragua, and Kenya, among others.

World Vision’s partnership approach emphasizes integration, sustainability, and last-mile reach, ensuring that Global Fund investments translate into tangible health outcomes for the most vulnerable populations. 

 

Our Impact in 2024

 

In 2024, World Vision’s Global Fund–supported continued to deliver life-saving impact at scale, addressing critical global health challenges related to malaria, tuberculosis, and HIV across 15 high-burden and fragile countries. Through these programmes, we reached over 24 million people with prevention, diagnostic, treatment, and health system–strengthening interventions. 

Our malaria programmes alone reached approximately 23 million people, distributing over 1 million insecticide-treated nets, conducting nearly 19 million parasitological tests, and ensuring more than 10 million confirmed malaria cases received effective treatment. In tuberculosis programming, we supported the identification of over 77,000 TB cases, initiated more than 61,000 people on TB treatment, and provided TB preventive therapy to over 32,000 individuals, including people living with HIV and household contacts.

In HIV and TB/HIV programmes, we reached more than 700,000 people, supported over 343,000 people living with HIV on antiretroviral therapy, expanded HIV testing among key and vulnerable populations, and strengthened differentiated service delivery models to improve retention and viral suppression. Collectively, our 2024 results demonstrate World Vision’s continued commitment to protecting hard-won gains, sustaining essential services, and improving health outcomes for the most vulnerable communities.

Each of the 70 million lives saved by the Global Fund partnership is a person – a parent, a child, a teacher, a worker, a neighbor or a friend. Every life saved, and every infection averted, has a multiplier effect across families, communities and entire nations.

Who are we reaching?

 

Together, the Global Fund and World Vision reach communities with the highest HIV, TB, and malaria burden, including populations living in remote, fragile, conflict-affected, and humanitarian settings. All World Vision–supported Global Fund programmes align with national strategies and apply evidence-based, community-centered approaches to ensure equitable access to services.

The Global Fund’s work to end AIDS, TB and malaria is aligned with Sustainable Development Goal 3: Ensure healthy lives and promote well-being for all at all ages. Our partnership’s results directly contribute to progress toward this and other goals.

Global Fund grants also contribute to sustainable health results in communities in alignment with the World Vision Child Well Being goal of "children ages 0 to 5 are protected from infection and disease." 

Grant Cycles

The Global Fund to fight AIDS, Tuberculosis, and Malaria operates on a structured grant cycle, typically lasting three years, though this duration can vary based on specific programme needs and circumstances. World Vision has been implementing Global Fund grants since the organization's inception in 2002, spanning multiple grant cycles.

Global Fund Engagement

 

World Vision is a founding member of the Civil Society Principal Recipients Network (CSPRN) and took on the co-chair role from 2015 to 2018. The CSPRN is a membership coalition of national and international NGO implementing partners who share best practices and lessons learned around grant implementation. CSPRN also provides feedback and input on improved regulations and systems that support better quality grant management globally.

World Vision Global Fund Contact

 

For more information or general questions about the Global Fund, please contact:

Eseza Ikedit, Resource Development Director

David Livingstone, Global Fund Unit Coordinator